Impact of Hypertension on the Prognosis of COVID-19 Disease and Uncertainties that Need to be Clarified

Sanlialp, Sara Cetin; Sanlialp, Musa

doi:10.1177/00033197211032784

Cited by 3 publications

(5 citation statements)

References 14 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Various studies focused on this issue. 14 , 15 A review of 16 studies showed that the evidence does not suggest higher risks for SARS-CoV-2 infection or poor prognosis for COVID-19 patients treated with renin angiotensin aldosterone system (RAAS) inhibitors. 16 The American Heart Association and European Society for Cardiology confirmed this issue.…”

Section: Discussionmentioning

confidence: 99%

Does COVID-19 Cause Hypertension?

Akpek¹

2021

Angiology

View full text Add to dashboard Cite

The coronavirus disease 2019 (COVID-19) outbreak remains a major public health challenge worldwide. The present study investigated the effect of COVID-19 on blood pressure (BP) during short term follow-up. A total of 211 consecutive COVID-19 patients who were admitted to Parkhayat Kutahya hospital were retrospectively screened. Information was obtained from the electronic medical records and National health data registry. The study outcome was new onset of hypertension according to the Eight Joint National Committee and European Society of Cardiology Guidelines. Finally, 153 confirmed COVID-19 patients (mean age 46.5 ± 12.7 years) were enrolled. Both systolic (120.9 ± 7.2 vs 126.5 ± 15.0 mmHg, P <.001) and diastolic BP (78.5 ± 4.4 vs 81.8 ± 7.4 mmHg, P <.001) were significantly higher in the post COVID-19 period than on admission. New onset hypertension was observed in 18 patients at the end of 31.6 ± 5.0 days on average ( P <.001). These findings suggest that COVID-19 increases systolic and diastolic BP and may cause new onset hypertension.

show abstract

Section: Discussionmentioning

confidence: 99%

Does COVID-19 Cause Hypertension?

Akpek¹

2021

Angiology

View full text Add to dashboard Cite

show abstract

“…A review of 16 studies showed that the evidence does not suggest higher risks for SARS-CoV-2 infection or poor prognosis for COVID-19 patients treated with renin angiotensin aldosterone system (RAAS) inhibitors. The American Heart Association and European Society for Cardiology confirmed this issue [21][22][23].…”

Section: Resultsmentioning

confidence: 77%

The Impact of Hypertension on Covid-19 Severity: A Global Review

Mamyrova,

Manvendra,

Murzabek kyzy

2023

ВОГУМ

View full text Add to dashboard Cite

Hypertension, also known as high blood pressure, is a prevalent medical condition that can exacerbate the severity of coronavirus disease 2019 (COVID-19). Studies from around the globe have shown that hypertensive patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) tend to experience more severe symptoms and have poorer outcomes. A meta-analysis of eight studies from China found that hypertensive patients were over twice as likely to develop severe COVID-19 illness that requires intensive care unit admission, mechanical ventilation or results in death. Several other analyzes of data from China, Italy, and the United States have come to similar conclusions, showing roughly double the risk of adverse outcomes in hypertensive patients. In summary, hypertension appears strongly linked to worse COVID-19 outcomes across the world. Patients should maintain good blood pressure control and take recommended precautions to avoid SARS-CoV-2 infection. Clinicians should closely monitor hypertensive patients diagnosed with COVID-19 due to their increased risk of critical illness. Continued research on how hypertension influences COVID-19 severity can help guide therapeutic approaches for this high-risk population.

show abstract

“…We thank Sanlialp et al for their comments 1 regarding our study entitled “Can C-reactive protein to albumin ratio predict in-hospital death rate due to COVID-19 in patients with hypertension?” 2 …”

mentioning

confidence: 99%

“…Sanlialp et al 1 cited 2 studies on the relationship between the grade of HT, and hospitalization, and adverse outcomes. In the first study, the description of good or bad blood pressure (BP) groups was based on BP measurements in the morning and afternoon.…”

mentioning

confidence: 99%

“…Reply to Letter: "Impact of Hypertension on the Prognosis of COVID-19 Disease and Uncertainties that Need to be Clarified" Faysal Saylik, MD 1 , Tayyar Akbulut, MD 1 and Safak Kaya, MD 2 We thank Sanlialp et al for their comments 1 regarding our study entitled "Can C-reactive protein to albumin ratio predict in-hospital death rate due to COVID-19 in patients with hypertension?" 2 In our study, 2 all hypertensive patients were selected consecutively and then classified as survivors and nonsurvivors.…”

mentioning

confidence: 99%

See 1 more Smart Citation